Earnings Outlook For RVL Pharmaceuticals plc - Ordinary Shares

RVL Pharmaceuticals plc - Ordinary Shares RVLP is set to give its latest quarterly earnings report on Monday, 2023-03-20. Here's what investors need to know before the announcement.

Analysts estimate that RVL Pharmaceuticals plc - Ordinary Shares will report an earnings per share (EPS) of $-0.16.

RVL Pharmaceuticals plc - Ordinary Shares bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Past Earnings Performance

Last quarter the company missed EPS by $0.00, which was followed by a 0.0% drop in the share price the next day.

Here's a look at RVL Pharmaceuticals plc - Ordinary Shares's past performance and the resulting price change:

Quarter Q3 2022 Q2 2022 Q1 2022 Q4 2021
EPS Estimate -0.16 -0.14 -0.21 -0.27
EPS Actual -0.16 -0.14 -0.08 -0.30
Price Change % 0.0% 5.32% 4.32% -3.43%

eps graph

Stock Performance

Shares of RVL Pharmaceuticals plc - Ordinary Shares were trading at $1.25 as of March 16. Over the last 52-week period, shares are down 32.8%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release.

To track all earnings releases for RVL Pharmaceuticals plc - Ordinary Shares visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Posted In: EarningsBZI-EP
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!